# HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

> **NCT07233070** · PHASE2 · RECRUITING · sponsor: **Fujian Shengdi Pharmaceutical Co., Ltd.** · enrollment: 208 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** HRS-7450 Injection
- **DRUG:** HRS-7450 Injection
- **DRUG:** HRS-7450 Injection
- **DRUG:** HRS-7450 Injection Placebo

## Key facts

- **NCT ID:** NCT07233070
- **Lead sponsor:** Fujian Shengdi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 208 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07233070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07233070, "HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07233070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*